Skip to main content

Advertisement

Log in

Syndrome of inappropriate secretion of antidiuretic hormone as an initial sign of primary central nervous system lymphomas in the hypothalamus

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Background

Primary central nervous system lymphoma (PCNSL) rarely originates in the hypothalamus. Hypothalamic PCNSL can present with various symptoms specific to dysfunction of the hypothalamus, including consciousness disturbance, cognitive impairment, hypopituitarism, and diabetes insipidus (DI). However, it remains unclear whether syndrome of inappropriate secretion of antidiuretic hormone (SIADH) can present as an initial sign of hypothalamic PCNSL.

Methods

Ninety-nine patients with PCNSL were diagnosed between January 2006 and December 2020 at our institutes. The initial symptoms and signs, hypothalamic–pituitary functions, serum sodium (Na) value, Karnofsky Performance Status (KPS) score on admission, and duration from onset to diagnosis were retrospectively investigated from the medical charts.

Results

Eight and 91 patients had hypothalamic PCNSL (hypothalamic group) and PCNSL located in other regions (control group), respectively. Patients’ pathological diagnoses were diffuse large B-cell lymphoma (97 patients) and intravascular lymphoma (two patients). Six patients presented with hyponatremia derived from SIADH or suspected SIADH, and one presented with DI. Statistically significant differences between the hypothalamic and control groups were detected only in the preoperative serum Na values and KPS scores.

Conclusion

SIADH can be an initial presentation of hypothalamic PCNSL. Early detection of hypothalamic PCNSL from SIADH may lead to proper management and improved prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability statement

The datasets generated for this study are available upon request to the corresponding author.

References

  1. Ichikawa T (2018) Primary CNS lymphoma treatment: current status and future directions. Jpn J Neurosurg 27:99–110. https://doi.org/10.7887/jcns.27.99

    Article  Google Scholar 

  2. Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol 21:v1–v100. https://doi.org/10.1093/neuonc/noz150

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tanki HN, Malik KN, Makhdoomi R, Feroz S, Ramzan AU (2018) Primary hypothalamic lymphoma in an adult male: a case report and literature review. Oman Med J 33:346–351. https://doi.org/10.5001/omj.2018.63

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shin DW, Kim JH, Kim YH, Cho YH, Hong SH (2020) Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis. J Neurooncol 147:339–349. https://doi.org/10.1007/s11060-020-03422-x

    Article  PubMed  Google Scholar 

  5. Higashi S, Yamashita J, Fujisawa H, Yamamoto Y, Kadoya M (1990) “Moustache” appearance in craniopharyngiomas: unique magnetic resonance imaging and computed tomographic findings of perifocal edema. Neurosurgery 27:993–996. https://doi.org/10.1227/00006123-199012000-00023

    Article  CAS  PubMed  Google Scholar 

  6. Pascual JM, González-Llanos F, Roda JM (2002) Primary hypothalamic-third ventricle lymphoma. Case report and review of the literature. Neurocirugia (Astur) 13:305–310. https://doi.org/10.1016/s1130-1473(02)70605-2

    Article  CAS  PubMed  Google Scholar 

  7. Lee MT, Lee TI, Won JG, Chau WK, Yang HJ, Li JC, Lin HD, Tang KT (2004) Primary hypothalamic lymphoma with panhypopituitarism presenting as stiff-man syndrome. Am J Med Sci 328:124–128. https://doi.org/10.1097/00000441-200408000-00010

    Article  PubMed  Google Scholar 

  8. Ikeda T, Hara K, Yamanaka T, Umezu H, Takahashi H, Nishizawa M (2006) A case of primary central nervous system malignant lymphoma developing from the optic chiasma and hypothalamus. Rinsho Shinkeigaku 46:475–479

    PubMed  Google Scholar 

  9. Prochazka V, Kubova Z, Raida L, Papajik T, Paucek B, Indrak K (2009) Cerebral salt wasting syndrome in a patient with primary CNS lymphoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 153:219–220. https://doi.org/10.5507/bp.2009.037

    Article  PubMed  Google Scholar 

  10. Yasuda M, Akiyama N, Miyamoto S, Warabi M, Takahama Y, Kitamura M, Yakushiji F, Kinoshita H (2010) Primary sellar lymphoma: intravascular large B-cell lymphoma diagnosed as a double cancer and improved with chemotherapy, and literature review of primary parasellar lymphoma. Pituitary 13:39–47. https://doi.org/10.1007/s11102-009-0196-9

    Article  PubMed  Google Scholar 

  11. López Navia AM, Galván Díaz B, Tejera Pérez C, Hernández Lavado R, Morales Pérez F (2014) Hypothalamic evanescent lesion by diffuse large B-cell lymphoma. Endocrinol Nutr 61:335–336. https://doi.org/10.1016/j.endonu.2014.03.005

    Article  PubMed  Google Scholar 

  12. Cellina M, Fetoni V, Baron P, Orsi M, Oliva G (2015) Unusual primary central nervous system lymphoma location involving the fourth ventricle and hypothalamus. Neuroradiol J 28:120–125. https://doi.org/10.1177/1971400915576671

    Article  PubMed  PubMed Central  Google Scholar 

  13. Takase R, Nakano Y, Otsuka F (2020) Malignant lymphoma developed in the hypothalamus. Intern Med 59:1009–1010. https://doi.org/10.2169/internalmedicine.3655-19

    Article  PubMed  Google Scholar 

  14. Antic D, Smiljanic M, Bila J, Jankovic S, Balint MT, Andjelic B, Mihaljevic B (2012) Hypothalamic dysfunction in a patient with primary lymphoma of the central nervous system. Neurol Sci 33:387–390. https://doi.org/10.1007/s10072-011-0726-x

    Article  PubMed  Google Scholar 

  15. Calanchini M, Cudlip S, Hofer M, Byrne J, Fabbri A, Grossman A (2016) Chordoid glioma of the third ventricle: a patient presenting with SIADH and a review of this rare tumor. Pituitary 19:356–361. https://doi.org/10.1007/s11102-016-0711-8

    Article  PubMed  Google Scholar 

  16. Cui H, He G, Yang S, Lv Y, Jiang Z, Gang X, Wang G (2019) Inappropriate antidiuretic hormone secretion and cerebral salt-wasting syndromes in neurological patients. Front Neurosci 13:1170. https://doi.org/10.3389/fnins.2019.01170

    Article  PubMed  PubMed Central  Google Scholar 

  17. Olchovsky D, Ezra D, Vered I, Hadani M, Shimon I (2005) Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition. J Endocrinol Invest 28:151–156. https://doi.org/10.1007/BF03345358

    Article  CAS  PubMed  Google Scholar 

  18. Rubacha M, Tubbs RS, Li R, Rocque B, Blount JP (2015) Pediatric central nervous system solitary fibrous tumor: case report. Childs Nerv Syst 31:2379–2381. https://doi.org/10.1007/s00381-015-2761-z

    Article  PubMed  Google Scholar 

  19. Schrier RW, Berl T, Anderson RJ (1979) Osmotic and nonosmotic control of vasopressin release. Am J Physiol 236:F321–F332. https://doi.org/10.1152/ajprenal.1979.236.4.F321

    Article  CAS  PubMed  Google Scholar 

  20. Ma SK, Lee KH, Kim SW (2014) Hyponatremia associated with primary central nervous system lymphoma. Clin Exp Nephrol 18:170–171. https://doi.org/10.1007/s10157-013-0839-z

    Article  PubMed  Google Scholar 

  21. Akhtar S, Cheesman E, Jude EB (2013) SIADH and partial hypopituitarism in a patient with intravascular large B-cell lymphoma: a rare cause of a common presentation. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-007147

    Article  PubMed  PubMed Central  Google Scholar 

  22. Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ (1992) Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23:9–17. https://doi.org/10.1016/0360-3016(92)90538-s

    Article  CAS  PubMed  Google Scholar 

  23. Ferreri AJ, Blay JY, Reni M et al (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 21:266–272. https://doi.org/10.1200/JCO.2003.09.139

    Article  PubMed  Google Scholar 

  24. Ferreri AJ, Reni M (2005) Prognostic factors in primary central nervous system lymphomas. Hematol Oncol Clin North Am 19:629–649. https://doi.org/10.1016/j.hoc.2005.05.005

    Article  PubMed  Google Scholar 

  25. Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24:5711–5715. https://doi.org/10.1200/JCO.2006.08.2941

    Article  PubMed  Google Scholar 

Download references

Funding

No funding was received for conducting this study.

Author information

Authors and Affiliations

Authors

Contributions

MO designed the study, analyzed data, and wrote the paper. YH designed the study and co-wrote the paper. YS advised on the study and edited the paper. NO analyzed the data. MN supervised the study.

Corresponding author

Correspondence to Masahiro Oishi.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval and consent to participate

This study was approved by the medical ethics committee at Kanazawa University (approval number: #2016-244 [2227]) and Kanazawa Medical University Hospital (approval number: #1556), and most participants provided written informed consent. Medical Ethics Committee of Kanazawa University waived the requirement of an informed consent considering the retrospective evaluation of patient data for the remaining patients, and written informed consent was not obtained from a relative/guardian. This study was performed in accordance with the Declaration of Helsinki and in compliance with requirements for retrospective studies on human subjects.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oishi, M., Hayashi, Y., Sasagawa, Y. et al. Syndrome of inappropriate secretion of antidiuretic hormone as an initial sign of primary central nervous system lymphomas in the hypothalamus. Acta Neurol Belg 123, 415–422 (2023). https://doi.org/10.1007/s13760-022-01985-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-022-01985-2

Keywords

Navigation